Drug application
HYDROXYPROGESTERONE CAPROATE (HYDROXYPROGESTERONE CAPROATE)
Drugs@FDA ANDA 200271 · ASPEN GLOBAL INC
Key facts
| Drug name | HYDROXYPROGESTERONE CAPROATE |
|---|---|
| Active ingredients | HYDROXYPROGESTERONE CAPROATE |
| Application type | ANDA |
| Application number | 200271 |
| Company | ASPEN GLOBAL INC |
| Dosage forms | SOLUTION, INTRAMUSCULAR |
| Strength | 1250MG/5ML (250MG/ML) |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Not Applicable |
| Latest submission status date | Aug 24, 2015 |
At a glance
- 1–9 Submissions
- 1–9 Label versions
- 1–9 Products
- None Therapeutic equivalents
- Yes FDA letters on file
- No FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: